new semaglutide pill Novo rings in year with US launch of Wegovy Novo Nordisk to Seek Approval

2021;22:e13177

Will high protein intake interfere with my GLP-1 results

Latin America held a 3% share of the market in 2025 and is expected to grow at a significant CAGR of 14% during the projection period, driven by GLP-1 medications that are driving structural health and economic shifts across Latin America by curbing surging obesity and type-2 diabetes rates, spurring vast biopharma investments, and fundamentally changing consumer habits in the fast-moving consumer goods sector

Most standard titration protocols reach therapeutic maintenance dose within 4-6 weeks of once-weekly injections

When should I go to hospital if I have diabetes and foot problems

Xiao, X., Lu, H., Zhu, W., Zhang, Y., Huo, X., Yang, C., et al., Microbiol